253 related articles for article (PubMed ID: 14557375)
1. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK.
Small GW; Somasundaram S; Moore DT; Shi YY; Orlowski RZ
J Pharmacol Exp Ther; 2003 Dec; 307(3):861-9. PubMed ID: 14557375
[TBL] [Abstract][Full Text] [Related]
2. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role.
Small GW; Shi YY; Edmund NA; Somasundaram S; Moore DT; Orlowski RZ
Mol Pharmacol; 2004 Dec; 66(6):1478-90. PubMed ID: 15448190
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
Shi YY; Small GW; Orlowski RZ
Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
Small GW; Shi YY; Higgins LS; Orlowski RZ
Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361
[TBL] [Abstract][Full Text] [Related]
5. Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice.
Marchetti S; Gimond C; Roux D; Gothié E; Pouysségur J; Pagès G
J Cell Physiol; 2004 Jun; 199(3):441-50. PubMed ID: 15095291
[TBL] [Abstract][Full Text] [Related]
6. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
Rojo F; González-Navarrete I; Bragado R; Dalmases A; Menéndez S; Cortes-Sempere M; Suárez C; Oliva C; Servitja S; Rodriguez-Fanjul V; Sánchez-Pérez I; Campas C; Corominas JM; Tusquets I; Bellosillo B; Serrano S; Perona R; Rovira A; Albanell J
Clin Cancer Res; 2009 May; 15(10):3530-9. PubMed ID: 19417026
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1.
Newton R; King EM; Gong W; Rider CF; Staples KJ; Holden NS; Bergmann MW
Biochem J; 2010 Mar; 427(1):113-24. PubMed ID: 20100175
[TBL] [Abstract][Full Text] [Related]
11. Temporal regulation of light-induced extracellular signal-regulated kinase activation in the suprachiasmatic nucleus.
Butcher GQ; Lee B; Obrietan K
J Neurophysiol; 2003 Dec; 90(6):3854-63. PubMed ID: 12930817
[TBL] [Abstract][Full Text] [Related]
12. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids.
Toh ML; Yang Y; Leech M; Santos L; Morand EF
Arthritis Rheum; 2004 Oct; 50(10):3118-28. PubMed ID: 15476200
[TBL] [Abstract][Full Text] [Related]
13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
14. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry.
Brunet A; Roux D; Lenormand P; Dowd S; Keyse S; Pouysségur J
EMBO J; 1999 Feb; 18(3):664-74. PubMed ID: 9927426
[TBL] [Abstract][Full Text] [Related]
15. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
Zhou JY; Liu Y; Wu GS
Cancer Res; 2006 May; 66(9):4888-94. PubMed ID: 16651445
[TBL] [Abstract][Full Text] [Related]
16. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M
Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639
[TBL] [Abstract][Full Text] [Related]
17. The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.
Givant-Horwitz V; Davidson B; Goderstad JM; Nesland JM; Tropé CG; Reich R
Gynecol Oncol; 2004 May; 93(2):517-23. PubMed ID: 15099972
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
[TBL] [Abstract][Full Text] [Related]
19. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells.
Wang Z; Yang H; Tachado SD; Capó-Aponte JE; Bildin VN; Koziel H; Reinach PS
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5267-75. PubMed ID: 17122112
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation.
Fürst R; Brueckl C; Kuebler WM; Zahler S; Krötz F; Görlach A; Vollmar AM; Kiemer AK
Circ Res; 2005 Jan; 96(1):43-53. PubMed ID: 15569826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
